These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 26027904)
1. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Arguello G; Balboa E; Arrese M; Zanlungo S Biochim Biophys Acta; 2015 Sep; 1852(9):1765-78. PubMed ID: 26027904 [TBL] [Abstract][Full Text] [Related]
2. The Role of Cholesterol in the Pathogenesis of NASH. Ioannou GN Trends Endocrinol Metab; 2016 Feb; 27(2):84-95. PubMed ID: 26703097 [TBL] [Abstract][Full Text] [Related]
3. Role of Cholesterol-Associated Steatohepatitis in the Development of NASH. Horn CL; Morales AL; Savard C; Farrell GC; Ioannou GN Hepatol Commun; 2022 Jan; 6(1):12-35. PubMed ID: 34558856 [TBL] [Abstract][Full Text] [Related]
4. Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. Arab JP; Arrese M; Trauner M Annu Rev Pathol; 2018 Jan; 13():321-350. PubMed ID: 29414249 [TBL] [Abstract][Full Text] [Related]
5. Decoding cell death signals in liver inflammation. Brenner C; Galluzzi L; Kepp O; Kroemer G J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086 [TBL] [Abstract][Full Text] [Related]
6. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Kumar S; Duan Q; Wu R; Harris EN; Su Q Adv Drug Deliv Rev; 2021 Sep; 176():113869. PubMed ID: 34280515 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis. Domínguez-Pérez M; Simoni-Nieves A; Rosales P; Nuño-Lámbarri N; Rosas-Lemus M; Souza V; Miranda RU; Bucio L; Uribe Carvajal S; Marquardt JU; Seo D; Gomez-Quiroz LE; Gutiérrez-Ruiz MC J Cell Physiol; 2019 May; 234(5):7213-7223. PubMed ID: 30239004 [TBL] [Abstract][Full Text] [Related]
9. From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria. Amorim R; Magalhães CC; Borges F; Oliveira PJ; Teixeira J Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106795 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Musso G; Gambino R; Cassader M Prog Lipid Res; 2013 Jan; 52(1):175-91. PubMed ID: 23206728 [TBL] [Abstract][Full Text] [Related]
11. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Su Q; Kumar V; Sud N; Mahato RI Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222 [TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease. Zhou L; Shen H; Li X; Wang H Front Immunol; 2022; 13():951406. PubMed ID: 35958574 [TBL] [Abstract][Full Text] [Related]
19. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Ahsan F; Oliveri F; Goud HK; Mehkari Z; Mohammed L; Javed M; Althwanay A; Rutkofsky IH Cureus; 2020 Sep; 12(9):e10446. PubMed ID: 33072455 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]